169 related articles for article (PubMed ID: 31254226)
1. Clinical evaluation of performance, biocompatibility, and safety of vitamin E-bonded polysulfone membrane hemodialyzer compared to non-vitamin E-bonded hemodialyzer.
Kiaii M; Aritomi M; Nagase M; Farah M; Jung B
J Artif Organs; 2019 Dec; 22(4):307-315. PubMed ID: 31254226
[TBL] [Abstract][Full Text] [Related]
2. Development of vitamin E-modified polysulfone membrane dialyzers.
Sasaki M
J Artif Organs; 2006; 9(1):50-60. PubMed ID: 16614802
[TBL] [Abstract][Full Text] [Related]
3. Safety of a Novel Dialyzer Containing a Fluorinated Polyurethane Surface-Modifying Macromolecule in Patients with End-Stage Kidney Disease.
Meyer JM; Steer D; Weber LA; Zeitone AA; Thakuria M; Ho CH; Aslam S; Mullon C; Kossmann RJ
Blood Purif; 2021; 50(6):959-967. PubMed ID: 33789265
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
5. Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer.
Matsumura M; Sasaki H; Sekizuka K; Sano H; Ogawa K; Shimizu C; Yoshida H; Kobayashi S; Koremoto M; Aritomi M; Ueki K
Int J Artif Organs; 2010 Mar; 33(3):147-53. PubMed ID: 20383856
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
7. A comparison of three brands of polysulfone membranes.
Hoenich NA; Woffindin C; Brennan A; Cox PJ; Matthews JN; Goldfinch M
J Am Soc Nephrol; 1996 Jun; 7(6):871-6. PubMed ID: 8793795
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.
Sanaka T; Mochizuki T; Kinugasa E; Kusano E; Ohwada S; Kuno T; Kojima K; Kobayashi S; Satoh M; Shimada N; Nakao K; Nakazawa R; Nishimura H; Noiri E; Shigematsu T; Tomo T; Maeda T;
Clin J Am Soc Nephrol; 2013 Jun; 8(6):969-78. PubMed ID: 23599410
[TBL] [Abstract][Full Text] [Related]
9. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.
MacGinley R; Westhuyzen J; Saltissi D; Morgan C; Healy H; Thirlwell GK; Disney AP
ASAIO J; 2001; 47(1):66-73. PubMed ID: 11199319
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance of a new high-flux synthetic membrane.
Hoenich NA; Stamp S
Am J Kidney Dis; 2000 Aug; 36(2):345-52. PubMed ID: 10922313
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes.
Piroddi M; Pilolli F; Aritomi M; Galli F
Am J Nephrol; 2012; 35(6):559-72. PubMed ID: 22677717
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E-coated membrane dialyzer and beta2-microglobulin removal.
Mandolfo S; Bucci R; Imbasciati E
Artif Organs; 2003 Dec; 27(12):1123-7. PubMed ID: 14678427
[TBL] [Abstract][Full Text] [Related]
15. Effects of novel manufacturing technology on blood and dialysate flow distribution in a new low flux "alpha Polysulfone" hemodialyzer.
Gastaldon F; Brendolan A; Crepaldi C; Frisone P; Zamboni S; d'Intini V; Poulin S; Hector R; Granziero A; Martins K; Gellert R; Inguaggiato P; Ronco C
Int J Artif Organs; 2003 Feb; 26(2):105-12. PubMed ID: 12653343
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vitamin E-bonded polysulfone dialyzer and polysulfone dialyzer on a series of non-anticoagulant hemodialysis.
Torato T; Doi K; Negishi K; Hamasaki Y; Satonaka H; Hanafusa N; Noiri E
ASAIO J; 2013; 59(3):284-5. PubMed ID: 23644616
[TBL] [Abstract][Full Text] [Related]
17. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
18. Determination of bisphenol a in effluents of hemodialyzers.
Yamasaki H; Nagake Y; Makino H
Nephron; 2001 Aug; 88(4):376-8. PubMed ID: 11474234
[TBL] [Abstract][Full Text] [Related]
19. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
20. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
